Table 2 Univariate and multivariate Cox regression analysis RNF157-AS1 for OS, PFS, or PPS of EOC patients in TCGA database.
Variables | OS | PFS | PPS | ||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | |
Univariate analysis | |||||||||
Age (<60 vs. ≥60) | 1.371 | 1.074–1.749 | 0.011* | 1.132 | 0.888–1.444 | 0.317 | 1.321 | 1.033–1.689 | 0.027* |
TNM stage (I/II vs. III/IV) | 1.958 | 0.923–4.157 | 0.080 | 1.279 | 0.980–1.668 | 0.070 | 1.433 | 0.675–3.041 | 0.349 |
Grade (G1/G2 vs. G3/G4) | 1.139 | 0.802–1.616 | 0.467 | 1.055 | 0.765–1.455 | 0.745 | 1.203 | 0.844–1.715 | 0.306 |
Site (unilateral vs. bilateral) | 1.070 | 0.799–1.434 | 0.648 | 1.109 | 0.858–1.435 | 0.428 | 1.029 | 0.768–1.378 | 0.849 |
Neoplasm status (tumor free vs. with tumor) | 7.912 | 4.501–13.907 | <0.001* | 5.578 | 3.816–8.152 | <0.001* | 3.882 | 2.212–6.815 | <0.001* |
Lymphatic invasion (no vs. yes) | 1.162 | 0.717–1.882 | 0.543 | 1.122 | 0.750–1.679 | 0.575 | 0.909 | 0.558–1.482 | 0.703 |
RNF157-AS1 expression (low vs. high) | 0.734 | 0.575–0.937 | 0.013* | 0.926 | 0.727–1.180 | 0.533 | 0.769 | 0.601–0.983 | 0.036* |
Multivariate analysis | |||||||||
Age(<60 vs. ≥60) | 1.267 | 0.976–1.645 | 0.075 | – | – | – | 1.253 | 0.963–1.630 | 0.093 |
Neoplasm status (tumor-free vs. with tumor) | 7.919 | 4.504–13.924 | <0.001* | 5.578 | 3.816–8.152 | <0.001* | 3.97 | 2.260–6.975 | <0.001* |
RNF157-AS1 expression (low vs. high) | 0.72 | 0.554–0.935 | 0.014* | – | – | – | 0.771 | 0.593–1.003 | 0.053 |